Martin McMahon

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 24

Top Topics

Epidermal Growth Factor Receptor

Top Venues

The Journal of experimental medicine

bioRxiv : the preprint server for biology

Pigment cell & melanoma research

This page only lists publications with an associated author ORCID identifier.

Publications

Martin McMahon, Dekker C Deacon
Spatial sequencing reveals transcriptional variation between amelanotic and pigmented acral melanoma. The British journal of dermatology (2024)
Phaedra C Ghazi, Kayla T O'Toole, Sanjana Srinivas Boggaram, Michael T Scherzer, Mark R Silvis, Yun Zhang, Madhumita Bogdan, Bryan D Smith, Guillermina Lozano, Daniel L Flynn, Eric L Snyder, Conan G Kinsey, Martin McMahon
Inhibition of ULK1/2 and KRAS G12C controls tumor growth in preclinical models of lung cancer. eLife 13 (2024)
Phaedra C Ghazi, Kayla T O'Toole, Sanjana Srinivas Boggaram, Michael T Scherzer, Mark R Silvis, Yun Zhang, Madhumita Bogdan, Bryan D Smith, Guillermina Lozano, Daniel L Flynn, Eric L Snyder, Conan G Kinsey, Martin McMahon
Inhibition of ULK1/2 and KRAS G12C controls tumor growth in preclinical models of lung cancer. eLife 13 (2024)
Phaedra C Ghazi, Kayla T O'Toole, Sanjana Srinivas Boggaram, Michael T Scherzer, Mark R Silvis, Yun Zhang, Madhumita Bogdan, Bryan D Smith, Guillermina Lozano, Daniel L Flynn, Eric L Snyder, Conan G Kinsey, Martin McMahon
Inhibition of ULK1/2 and KRAS G12C controls tumor growth in preclinical models of lung cancer. bioRxiv : the preprint server for biology (2024)
Phaedra C Ghazi, Kayla T O'Toole, Sanjana Srinivas Boggaram, Michael T Scherzer, Mark R Silvis, Yun Zhang, Madhumita Bogdan, Bryan D Smith, Guillermina Lozano, Daniel L Flynn, Eric L Snyder, Conan G Kinsey, Martin McMahon
Inhibition of ULK1/2 and KRAS G12C controls tumor growth in preclinical models of lung cancer. bioRxiv : the preprint server for biology (2024)
Phaedra C Ghazi, Kayla T O'Toole, Sanjana Srinivas Boggaram, Michael T Scherzer, Mark R Silvis, Yun Zhang, Madhumita Bogdan, Bryan D Smith, Guillermina Lozano, Daniel L Flynn, Eric L Snyder, Conan G Kinsey, Martin McMahon
Inhibition of ULK1/2 and KRAS G12C controls tumor growth in preclinical models of lung cancer. bioRxiv : the preprint server for biology (2024)
Aria Vaishnavi, Conan G Kinsey, Martin McMahon
Preclinical Modeling of Pathway-Targeted Therapy of Human Lung Cancer in the Mouse. Cold Spring Harbor perspectives in medicine (2023)
Mark R Silvis, Dilru Silva, Riley Rohweder, Sophia Schuman, Swapna Gudipaty, Amanda Truong, Jeffrey Yap, Kajsa E Affolter, Martin McMahon, Conan G Kinsey
MYC-mediated resistance to trametinib and HCQ in PDAC is overcome by CDK4/6 and lysosomal inhibition. The Journal of experimental medicine 220 (3) (2023)
Mark R Silvis, Dilru Silva, Riley Rohweder, Sophia Schuman, Swapna Gudipaty, Amanda Truong, Jeffrey Yap, Kajsa E Affolter, Martin McMahon, Conan G Kinsey
MYC-mediated resistance to trametinib and HCQ in PDAC is overcome by CDK4/6 and lysosomal inhibition. The Journal of experimental medicine 220 (3) (2023)
Mark R Silvis, Dilru Silva, Riley Rohweder, Sophia Schuman, Swapna Gudipaty, Amanda Truong, Jeffrey Yap, Kajsa E Affolter, Martin McMahon, Conan G Kinsey
MYC-mediated resistance to trametinib and HCQ in PDAC is overcome by CDK4/6 and lysosomal inhibition. The Journal of experimental medicine 220 (3) (2023)
Jackson R Richards, Donghan Shin, Rob Pryor, Lise K Sorensen, Zhonglou Sun, Won Mi So, Garam Park, Roger Wolff, Amanda Truong, Martin McMahon, Allie H Grossmann, J William Harbour, Weiquan Zhu, Shannon J Odelberg, Jae Hyuk Yoo
Activation of NFAT by HGF and IGF-1 via ARF6 and its effector ASAP1 promotes uveal melanoma metastasis. Oncogene (2023)
Mark R Silvis, Dilru Silva, Riley Rohweder, Sophia Schuman, Swapna Gudipaty, Amanda Truong, Jeffrey Yap, Kajsa E Affolter, Martin McMahon, Conan G Kinsey
MYC-mediated resistance to trametinib and HCQ in PDAC is overcome by CDK4/6 and lysosomal inhibition. The Journal of experimental medicine 220 (3) (2023)
Mark R Silvis, Dilru Silva, Riley Rohweder, Sophia Schuman, Swapna Gudipaty, Amanda Truong, Jeffrey Yap, Kajsa E Affolter, Martin McMahon, Conan G Kinsey
MYC-mediated resistance to trametinib and HCQ in PDAC is overcome by CDK4/6 and lysosomal inhibition. The Journal of experimental medicine 220 (3) (2023)
Jackson R Richards, Donghan Shin, Rob Pryor, Lise K Sorensen, Zhonglou Sun, Won Mi So, Garam Park, Roger Wolff, Amanda Truong, Martin McMahon, Allie H Grossmann, J William Harbour, Weiquan Zhu, Shannon J Odelberg, Jae Hyuk Yoo
Correction: Activation of NFAT by HGF and IGF-1 via ARF6 and its effector ASAP1 promotes uveal melanoma metastasis. Oncogene (2023)
Gennie L Parkman, Tursun Turapov, David A Kircher, William J Burnett, Christopher M Stehn, Kayla O'Toole, Katie M Culver, Ashley T Chadwick, Riley C Elmer, Ryan Flaherty, Karly A Stanley, Mona Foth, David H Lum, Robert L Judson, John E Friend, Matthew W VanBrocklin, Martin McMahon, Sheri L Holmen
Genetic silencing of AKT induces melanoma cell death via mTOR suppression. Molecular cancer therapeutics (2023)
Mark R Silvis, Dilru Silva, Riley Rohweder, Sophia Schuman, Swapna Gudipaty, Amanda Truong, Jeffrey Yap, Kajsa E Affolter, Martin McMahon, Conan G Kinsey
MYC-mediated resistance to trametinib and HCQ in PDAC is overcome by CDK4/6 and lysosomal inhibition. The Journal of experimental medicine 220 (3) (2023)
Aria Vaishnavi, Joseph Juan, Maebh Jacob, Christopher M Stehn, Eric E Gardner, Michael T Scherzer, Sophia Schuman, J Edward Van Veen, Brandon Murphy, Christopher S Hackett, Adam J Dupuy, Stephen A Chmura, Louise van der Weyden, Justin Y Newberg, Annie Liu, Karen M Mann, Alistair G Rust, William A Weiss, Conan G Kinsey, David J Adams, Allie H Grossmann, Michael B Mann, Martin McMahon
Transposon Mutagenesis Reveals RBMS3 Silencing as a Promoter of Malignant Progression of BRAFV600E-Driven Lung Tumorigenesis. Cancer research 82 (22) (2022)
Gennie L Parkman, Mona Foth, David A Kircher, Sheri L Holmen, Martin McMahon
The role of PI3'-lipid signalling in melanoma initiation, progression and maintenance. Experimental dermatology (2021)
Mona Foth, Gennie L Parkman, Benjamin Battistone, Martin McMahon
RAC1mutation is not a predictive biomarker for PI3'-kinase-β-selective pathway-targeted therapy. Pigment cell & melanoma research 33 (5) (2020)
Gennie L Parkman, David A Kircher, Christopher M Stehn, Martin McMahon, Sheri L Holmen
Model-dependent outcomes: Sex as a biological variable in preclinical mouse models of melanoma. Pigment cell & melanoma research 34 (3) (2020)
Amanda Truong, Jae Hyuk Yoo, Michael T Scherzer, John Michael S Sanchez, Kali J Dale, Conan G Kinsey, Jackson R Richards, Donghan Shin, Phaedra C Ghazi, Michael D Onken, Kendall J Blumer, Shannon J Odelberg, Martin McMahon
Chloroquine Sensitizes GNAQ/11-mutated Melanoma to MEK1/2 Inhibition. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (23) (2020)
J Edward Van Veen, Michael Scherzer, Julia Boshuizen, Mollee Chu, Annie Liu, Allison Landman, Shon Green, Christy Trejo, Martin McMahon
Mutationally-activated PI3'-kinase-α promotes de-differentiation of lung tumors initiated by the BRAFV600E oncoprotein kinase. eLife 8 (2019)
Conan G Kinsey, Soledad A Camolotto, Amelie M Boespflug, Katrin P Guillen, Mona Foth, Amanda Truong, Sophia S Schuman, Jill E Shea, Michael T Seipp, Jeffrey T Yap, Lance D Burrell, David H Lum, Jonathan R Whisenant, G Weldon Gilcrease, Courtney C Cavalieri, Kaitrin M Rehbein, Stephanie L Cutler, Kajsa E Affolter, Alana L Welm, Bryan E Welm, Courtney L Scaife, Eric L Snyder, Martin McMahon
Protective autophagy elicited by RAF→MEK→ERK inhibition suggests a treatment strategy for RAS-driven cancers. Nature medicine 25 (4) (2019)
Jillian M Silva, Marian M Deuker, Bruce C Baguley, Martin McMahon
PIK3CA-mutated melanoma cells rely on cooperative signaling through mTORC1/2 for sustained proliferation. Pigment cell & melanoma research 30 (3) (2017)